Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Medicine in Drug Discovery is Scopus-indexed (Q1, CiteScore 11.5), DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2590-0986Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 16 / 278 | 94th | Q1 |
| Pharmacology | 30 / 328 | 91st | Q1 |
| Drug Discovery | 18 / 161 | 89th | Q1 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q1, CiteScore 11.5.
Medicine in Drug Discovery is Q1 in Pharmacology (medical) (rank 16 of 278), Q1 in Pharmacology (rank 30 of 328) and Q1 in Drug Discovery (rank 18 of 161), by CiteScore 2025.
Medicine in Drug Discovery is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 11.5, quartile Q1, 94th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.145, quartile Q1, with an H-index of 28.
The publisher lists an article processing charge of about US$2,460 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Medicine in Drug Discovery is published by Elsevier B.V. Its ISSN is 2590-0986.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Medicine in Drug Discovery has an h-index of 46 and a 2-year mean of 8.4 citations per paper (OpenAlex). Its Scopus CiteScore is 11.5, quartile Q1. On 2-year citations it ranks #8 of 271 Scopus journals in Pharmacology (medical).
Medicine in Drug Discovery published 42 papers in 2025; its busiest recent year was 2020 with 57. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2023–2026), authors are most often from India (32.6%), China (12%) and Thailand (8.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.